Article
Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study
Fecha
2022Registro en:
SILVA, Thiago Cerqueira et.al. Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study. The Lancet Infectious Diseases, p. 1-11, 2022.
1474-4457
10.1016/S1473-3099(22)00140-2
Autor
Silva, Thiago Cerqueira
Andrews, Jason R.
Boaventura, Viviane S.
Ranzani, Otavio T.
Oliveira, Vinicius de Araújo
Paixão, Enny S.
Bertoldo Júnior, Juracy
Machado, Tales Mota
Hitchings, Matt D. T.
Dorion, Murilo
Lind, Margaret L.
Penna, Gerson O.
Cummings, Derek A. T.
Dean, Natalie E.
Werneck, Guilherme Loureiro
Pearce, Neil
Barreto, Mauricio L.
Ko, Albert I.
Croda, Julio
Barral-Netto, Manoel